Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
Revenue
Fuji Pharma Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
Revenue
¥41.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Fuji Pharma Co Ltd's Revenue?
Revenue
41.6B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Revenue amounts to 41.6B JPY.
What is Fuji Pharma Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Fuji Pharma Co Ltd have been 7% over the past three years , 2% over the past five years , and 5% over the past ten years .